Liang Shi
- Topics
- RNA modifications and cancer (6 papers)Cancer, Hypoxia, and Metabolism (4 papers)Thyroid Cancer Diagnosis and Treatment (4 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Liang Shi
37 papers receiving 821 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 502
- Cancer Research 275
- Oncology 130
- Pulmonary and Respiratory Medicine 87
- Epidemiology 67
Countries citing papers authored by Liang Shi
This map shows the geographic impact of Liang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Shi more than expected).
Fields of papers citing papers by Liang Shi
This network shows the impact of papers produced by Liang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Shi. The network helps show where Liang Shi may publish in the future.
Co-authorship network of co-authors of Liang Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Liang Shi. A scholar is included among the top collaborators of Liang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Shi. Liang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 46 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 60 | |
| 9 | 8 | |
| 10 | 18 | |
| 11 | Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer | 1 |
| 12 | 15 | |
| 13 | 12 | |
| 14 | 169 | |
| 15 | 19 | |
| 16 | 24 | |
| 17 | 18 | |
| 18 | 45 | |
| 19 | 41 | |
| 20 | 2 |
About Liang Shi
Liang Shi is a scholar working on Cancer Research, Physiology and Biological Psychiatry, having authored 39 papers that have together received 828 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (275 citations), Geriatrics and Gerontology (53 citations) and Molecular Biology (502 citations). Liang Shi has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Qiang Ding, Shuxian An, Wenbin Zhou, Ji‐Fu Wei, Tiansong Xia, Gang Huang, Mengda Cao, Jiayi Qian, Xi Sun and Shui Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.